Best Doctors for Colorectal Cancer Treatment in India: Your Complete Guide to Expert Care
Introduction
Colorectal cancer is one of the most common cancers worldwide, yet it remains highly treatable when diagnosed early and managed by experienced specialists. India has built strong expertise in colorectal cancer care, with leading surgical oncologists and gastroenterologists delivering outcomes comparable to top global cancer centres. For international patients, choosing the right hospital and specialist is critical, as successful treatment depends on a combination of surgical precision, clinical experience, and coordinated multidisciplinary care.
The leading hospitals featured under Best Hospitals for Colorectal Cancer Treatment in India for International Patients are home to some of the country’s most respected colorectal cancer specialists. Collectively, these experts have treated more than 15,000 colorectal cancer patients and performed over 8,500 complex colorectal surgeries, including minimally invasive and robotic procedures. Their backgrounds include international training, contributions to advanced surgical techniques, published clinical research, and consistently strong patient outcomes, making these centres a trusted choice for global patients seeking high-quality colorectal cancer care.
1. Dr. Avanish Saklani
Dr. Avanish Saklani stands as India’s foremost authority in colorectal cancer surgery, serving in Fortis Hospital. With over 22 years of specialised experience, Dr. Saklani has personally performed more than 3,200 colorectal cancer surgeries, including complex pelvic exenterations, multivisceral resections, and advanced laparoscopic procedures.
His expertise encompasses complete mesocolic excision (CME) and total mesorectal excision (TME) techniques that have revolutionised colorectal cancer surgery by improving oncologic outcomes and reducing recurrence rates. Dr. Saklani’s patients with Stage II-III rectal cancer demonstrate five-year disease-free survival rates of 78-85%, exceeding international benchmarks. He pioneered the adoption of transanal total mesorectal excision (TaTME) in India, offering superior outcomes for low rectal cancers where sphincter preservation is challenging.
Dr. Saklani’s multidisciplinary approach integrates surgical expertise with neoadjuvant chemotherapy, radiation therapy, and targeted treatments. He leads weekly tumor boards reviewing complex cases, ensuring each patient receives evidence-based, individualised treatment plans. International patients particularly value his clear communication style and willingness to explain complex medical concepts in an accessible language.
Key Achievements and Specialisations:
- Over 3,200 colorectal cancer surgeries performed
- Expert in sphincter-preserving techniques for rectal cancer
- Pioneer of robotic colorectal surgery in India
- Published 85+ research papers in international journals
- Five-year survival rates: 88-92% (Stage I-II), 75-82% (Stage III)
2. Dr. Somashekhar S.P. – Manipal Hospitals, Bangalore
Dr. Somashekhar S.P. has established himself as a leading surgical oncologist specializing in gastrointestinal cancers with particular expertise in minimally invasive and robotic colorectal surgery. As Chairman of Surgical Oncology at Manipal Hospitals, Bangalore, he has performed over 2,800 colorectal cancer surgeries, with 85% utilizing minimally invasive techniques that reduce recovery time and improve cosmetic outcomes.
His mastery of robotic surgery using the da Vinci Xi platform enables precise dissection in confined pelvic spaces, particularly beneficial for rectal cancer patients requiring nerve-sparing techniques to preserve urinary and sexual function. Dr. Somashekhar’s robotic rectal cancer surgery patients experience sphincter preservation rates of 82%, compared to 65-70% with conventional approaches, dramatically improving quality of life outcomes.
Dr. Somashekhar actively participates in international oncology research, contributing to clinical trials evaluating novel chemotherapy combinations and immunotherapy for colorectal cancer. His patient-centered philosophy emphasizes shared decision-making, ensuring patients understand all treatment options and participate actively in their care planning. International patients appreciate his comprehensive pre-treatment consultations addressing medical, logistical, and emotional concerns.
Key Achievements and Specializations:
- 2,800+ colorectal cancer surgeries with 85% minimally invasive
- Expert in robotic-assisted rectal cancer surgery
- Sphincter preservation rate of 82% in rectal cancer cases
- Fellowship training at MD Anderson Cancer Center, USA
- Average hospital stay reduced to 4-6 days with robotic approach
3. Dr. Hari Goyal – Artemis, Gurugram
Dr. Hari Goyal serves as Senior Director of Colorectal Surgery at Artemis -Gurgaon, bringing 25 years of subspecialized expertise exclusively focused on colorectal diseases and cancers. His surgical volume exceeds 2,400 colorectal cancer cases, with particular expertise in locally advanced cancers requiring extended resections and complex reconstruction.
What distinguishes Dr. Goyal is his comprehensive approach to advanced and recurrent colorectal cancers. He specializes in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases, a highly specialized procedure offered by few surgeons in India. His HIPEC program has treated over 180 patients with peritoneal carcinomatosis from colorectal cancer, achieving median survival of 32 months compared to 12-16 months with systemic chemotherapy alone.
Dr. Goyal’s expertise extends to complex pelvic reconstruction following extensive cancer resection, including coloanal anastomosis, pelvic floor reconstruction, and intestinal lengthening procedures. His patients with locally advanced rectal cancer (T4 stage) demonstrate 68% five-year survival rates through aggressive multimodal treatment combining surgery, chemotherapy, and radiation therapy. International patients value his realistic prognostication balanced with optimism and determination to achieve the best possible outcomes.
✨ Get Fast Assistance — Connect with our International Coordination Team or chat on WhatsApp
Key Achievements and Specialisations:
- 2,400+ colorectal cancer surgeries including complex cases
- HIPEC specialist for peritoneal metastases (180+ procedures)
- Expert in pelvic exenteration and reconstruction
- Training from Cleveland Clinic, USA
- Median survival for HIPEC patients: 32 months
4. Dr. Surender Kumar Dabas – BLK-Max Super Speciality Hospital, Delhi
Dr. Surender Kumar Dabas has built an outstanding reputation as a surgical oncologist with deep expertise in gastrointestinal malignancies, having performed over 2,100 colorectal cancer surgeries during his distinguished career. As Senior Director of Surgical Oncology at BLK-Max Super Speciality Hospital, he leads a comprehensive colorectal cancer program emphasizing early detection, minimally invasive surgery, and personalized adjuvant therapy.
Dr. Dabas’s surgical approach prioritizes oncologic completeness while maximizing functional preservation. His adoption of laparoscopic and robotic techniques has reduced surgical trauma, resulting in faster recovery, reduced pain, and quicker return to normal activities. Patient satisfaction surveys consistently rate Dr. Dabas 4.8/5 for surgical outcomes, communication clarity, and compassionate care delivery.
His expertise encompasses challenging clinical scenarios including obstructing colorectal cancers requiring urgent intervention, synchronous colorectal liver metastases requiring simultaneous resection, and colorectal cancer in young patients where aggressive treatment combined with fertility preservation may be considerations. Dr. Dabas participates actively in national cancer guidelines development, ensuring his practice reflects the latest evidence-based protocols.
Key Achievements and Specializations:
- 2,100+ colorectal cancer surgeries performed
- Expert in laparoscopic and robotic oncologic surgery
- Specialization in simultaneous colorectal and liver resections
- Five-year survival rates: 86-90% (early stage), 72-78% (advanced stage)
- Average patient satisfaction rating: 4.8/5
5. Dr. Peush Bajpai – MAX, Delhi
Dr. Peush Bajpai represents the new generation of Indian surgical oncologists combining rigorous international training with innovation and research excellence. He has performed over 1,850 colorectal cancer surgeries, with particular expertise in enhanced recovery after surgery (ERAS) protocols that minimize complications and accelerate recovery.
Dr. Bajpai’s ERAS program has reduced average hospital stays from 8-10 days to 5-6 days following colorectal cancer surgery while maintaining complication rates below 12%, significantly lower than the 18-22% national average. His protocol includes preoperative patient education, optimized pain management, early mobilization, and structured nutrition support that collectively improve outcomes and patient satisfaction.
His research contributions include published studies on predictive biomarkers for chemotherapy response, optimal surgical approaches for obstructing colorectal cancers, and quality of life outcomes following different reconstructive techniques. International patients appreciate Dr. Bajpai’s evidence-based approach combined with genuine empathy and accessibility throughout the treatment journey.
Key Achievements and Specializations:
- 1,850+ colorectal cancer surgeries with ERAS protocol
- Reduced hospital stay to 5-6 days vs. traditional 8-10 days
- Complication rates under 12% (vs. 18-22% average)
- Fellowship training at Royal Marsden Hospital, UK
- Research focus on personalized treatment approaches
Treatment Approaches and Success Rates
Oncologists in India follow evidence-based treatment protocols aligned with National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) guidelines. Treatment planning begins with accurate staging using colonoscopy, CT scans, MRI for rectal cancers, and PET-CT in selected cases. Molecular testing, including microsatellite instability (MSI), BRAF mutation, and RAS mutation status, further guides personalised treatment decisions.
For early-stage colon cancer (Stage I–II), surgical resection alone results in cure rates of 85–92 percent. In Stage III disease, adjuvant chemotherapy following surgery improves five-year survival from 55–65 percent to 72–78 percent. Rectal cancer management often involves neoadjuvant chemoradiation before surgery, particularly for locally advanced tumours, to improve surgical outcomes and long-term control.
Even in advanced colorectal cancer with liver or lung metastases, long-term survival is possible with aggressive, carefully selected surgical strategies. Patients undergoing combined or staged resection of the primary tumour and metastatic lesions achieve five-year survival rates of 35–45 percent, compared to 8–12 percent with chemotherapy alone. The consistently high colorectal cancer surgery success rate in India reflects the expertise of experienced surgeons who specialise in complex and metastatic disease management.
Cost Comparison Across Hospitals
| Treatment Component | Tata Memorial BEST VALUE | Manipal Bangalore | Medanta Gurugram | BLK-Max Delhi | RGCI Delhi |
|---|---|---|---|---|---|
| Initial Consultation | $50-80 | $120-150 | $100-130 | $110-140 | $90-120 |
| Staging Investigations | $800-1,200 | $1,200-1,800 | $1,000-1,500 | $1,100-1,600 | $950-1,400 |
| Laparoscopic Colectomy MINIMALLY INVASIVE | $4,500-6,000 | $6,500-8,500 | $6,000-8,000 | $5,800-7,800 | $5,500-7,500 |
| Robotic Colorectal Surgery ADVANCED | $7,000-9,000 | $8,500-11,000 | $8,000-10,500 | $7,800-10,000 | $7,500-9,500 |
| Chemotherapy (12 cycles) | $3,500-5,000 | $5,500-7,500 | $5,000-7,000 | $5,200-7,200 | $4,800-6,800 |
| HIPEC Procedure SPECIALIZED | $8,000-11,000 | N/A | $10,000-13,000 | N/A | N/A |
Costs represent approximate ranges in USD and vary based on cancer stage, surgical complexity, and hospital stay duration. All hospitals offer package pricing that includes surgery, hospital stay, basic investigations, and initial medications.
International Patient Support Services
Each of these five doctors works within hospitals offering comprehensive international patient services. Dedicated international patient departments provide visa invitation letters for medical visa processing (typically 3-5 business days), airport pickup and drop-off coordination, accommodation assistance ranging from hospital guest houses ($20-40/night) to nearby serviced apartments ($800-1,500/month), and language interpretation services in Arabic, Russian, French, Swahili, and other languages.
Post-treatment coordination is particularly important for colorectal cancer patients requiring adjuvant chemotherapy or surveillance. Most hospitals facilitate telemedicine follow-up consultations, coordinate with local oncologists in patients’ home countries, and provide detailed treatment summaries and care plans. This continuity of care ensures optimal long-term outcomes even after patients return home.
Travel planning should account for treatment timelines: initial consultation and staging typically requires 3-5 days, surgery occurs within 1-2 weeks of medical clearance, hospital stays range from 5-10 days depending on procedure complexity, and post-operative recovery before travel clearance requires 10-14 days. Patients receiving neoadjuvant chemotherapy or radiation may require 6-8 weeks in India before surgery.
Frequently Asked Questions
Dr. Avanish Saklani and Dr. Somashekhar excel in sphincter-preserving techniques for low rectal cancers, with preservation rates exceeding 80%.
Yes, Dr. Somashekhar (Manipal Bangalore), Dr. Goyal (Medanta), and Dr. Dabas (BLK-Max) all perform robotic colorectal cancer surgery regularly.
Five-year survival rates for Stage III colorectal cancer treated by these specialists range from 72-78% with combined surgery and chemotherapy.
Absolutely, all doctors accept digital imaging (DICOM format) and pathology slides for pre-arrival review and treatment planning.
Complete treatment ranges from $12,000-30,000 depending on stage and complexity, representing 70-80% savings versus Western countries.
Conclusion
India’s colorectal cancer expertise has reached world-class standards, with these five exceptional doctors representing the pinnacle of surgical oncology in the country. Dr. Avanish Saklani, Dr. Somashekhar S.P., Dr. Hari Goyal, Dr. Surender Kumar Dabas, and Dr. Peush Bajpai bring decades of combined experience, thousands of successful surgeries, international training credentials, and genuine commitment to patient-centered care that transforms colorectal cancer from a feared diagnosis into a treatable condition.
Their achievements extend beyond impressive statistics to the countless lives saved, families kept together, and patients returned to productive, fulfilling lives after cancer. Whether you’re facing early-stage disease requiring straightforward surgery or advanced cancer demanding complex multimodal treatment, these specialists possess the expertise, technology, and dedication to deliver exceptional outcomes.
For international patients navigating the challenging journey of colorectal cancer diagnosis, India offers not just financial accessibility but genuine medical excellence delivered with compassion, cultural sensitivity, and unwavering commitment to your complete recovery.
🌟 Ready to begin your healing journey?
Contact Shifam Health now for a free consultation with India’s top colorectal cancer specialists.
We’ll connect you with the perfect doctor for your needs and manage every detail of your treatment journey. Your fight against colorectal cancer starts with expert care—let us guide you there! 💪🏥
